Jay A Barth Selected Research

migalastat

9/2020	Long-term efficacy and safety of migalastat treatment in Fabry disease: 30-month results from the open-label extension of the randomized, phase 3 ATTRACT study.
2/2020	Efficacy and safety of migalastat in a Japanese population: a subgroup analysis of the ATTRACT study.
1/2019	Efficacy of the pharmacologic chaperone migalastat in a subset of male patients with the classic phenotype of Fabry disease and migalastat-amenable variants: data from the phase 3 randomized, multicenter, double-blind clinical trial and extension study.
1/2019	Pregnancy Outcome after Exposure to Migalastat for Fabry Disease: A Clinical Report.
1/2019	Safety of switching to Migalastat from enzyme replacement therapy in Fabry disease: Experience from the Phase 3 ATTRACT study.
1/2018	Migalastat improves diarrhea in patients with Fabry disease: clinical-biomarker correlations from the phase 3 FACETS trial.
11/2017	Reduction of podocyte globotriaosylceramide content in adult male patients with Fabry disease with amenable GLA mutations following 6 months of migalastat treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jay A Barth Research Topics

Disease

8	Fabry Disease (Fabry's Disease) 10/2021 - 11/2017
2	Wounds and Injuries (Trauma) 01/2020 - 01/2020
2	Diarrhea 01/2019 - 01/2018
1	Epidermolysis Bullosa 01/2020
1	Proteinuria 01/2019
1	Hypertension (High Blood Pressure) 01/2019

Drug/Important Bio-Agent (IBA)

7	migalastatIBA 09/2020 - 11/2017
3	globotriaosylceramide (globotriosylceramide)IBA 01/2019 - 11/2017
2	EnzymesIBA 10/2021 - 11/2017
2	AllantoinIBA 01/2020 - 01/2020
1	alpha-Galactosidase (Beano)IBA 10/2021
1	larazotide acetateIBA 09/2020
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	GalactosidasesIBA 11/2017

Therapy/Procedure

2	Enzyme Replacement Therapy 09/2020 - 01/2019
1	Pain Management 01/2020